Latest Share Chat

REMOVE ADS

ValiRx Share News (VAL)

ValiRx Information

Share Price Information for ValiRx (VAL)

Share Price is delayed by 15 minutes

Get Live Data

0.185 0.00 (0.00%)

Bid:

0.18

Ask:

0.19

Spread: 0.01 (5.556%)

Market Cap: £1.37m

Last checked at -

Intraday ValiRx Share Chart

REMOVE ADS

ValiRx News

LONDON MARKET OPEN: Stocks fall after Fed casts doubt on December cut

(Alliance News) - Stock prices in London opened lower on Thursday, as the FTSE 100 retreated from a record high in the wake of a "hawkish" cut by the ...

EARNINGS AND TRADING: Truspine loss widens; Abingdon's fund raise

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reporte...

EARNINGS: ValiRx says trading "challenging"; Mindflair swings to loss

(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Monday and not separately reported by Alliance News:

TRADING UPDATES: Wellnex makes Storelink its New Zealand distributor

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately report...

ValiRx's Cytolytix gets EU patent allowance for nanoparticles

(Alliance News) - ValiRx PLC on Monday said it has received a notice of allowance from the European Patent Office for "nanoparticle for anti-cancer pe...

AIM WINNERS & LOSERS: Mkango interim loss widens on China restrictions

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Monday.

ValiRx establishes new subsidiary for prostate cancer assets

(Alliance News) - ValiRx PLC on Tuesday announced its establishment of a new wholly-owned subsidiary, and plans to file new patents for Val201.

ValiRx launches prostate cancer subsidiary Blue Ribbon Bio

(Sharecast News) - ValiRx announced a new wholly owned subsidiary Blue Ribbon Bio on Tuesday, to consolidate its prostate cancer assets and accelerate...